Evidence map›Paper›PMID 36507076›Full record

ArticleCancer informatics2022

TULIP: An RNA-seq-based Primary Tumor Type Prediction Tool Using Convolutional Neural Networks.

Sara Jones, Matthew Beyers, Maulik Shukla, Fangfang Xia, Thomas Brettin, Rick Stevens, M Ryan Weil, Satishkumar Ranganathan Ganakammal

Open access · goldAbstract read
In one paragraph

Article in Cancer informatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sara JonesFrederick National Laboratory for Cancer Research, Cancer Data Science Initiatives, Cancer Research Technology Program, Rockville, MD, USA.
Matthew BeyersFrederick National Laboratory for Cancer Research, Cancer Data Science Initiatives, Cancer Research Technology Program, Rockville, MD, USA.
Maulik ShuklaArgonne National Laboratory, Computing, Environment and Life Sciences, Lemont, IL, USA.
Fangfang XiaArgonne National Laboratory, Computing, Environment and Life Sciences, Lemont, IL, USA.
Thomas BrettinArgonne National Laboratory, Computing, Environment and Life Sciences, Lemont, IL, USA.
Rick StevensArgonne National Laboratory, Computing, Environment and Life Sciences, Lemont, IL, USA.
M Ryan WeilFrederick National Laboratory for Cancer Research, Cancer Data Science Initiatives, Cancer Research Technology Program, Rockville, MD, USA.
Satishkumar Ranganathan GanakammalFrederick National Laboratory for Cancer Research, Cancer Data Science Initiatives, Cancer Research Technology Program, Rockville, MD, USA.
Argonne National Laboratory · USFrederick National Laboratory for Cancer Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With cancer as one of the leading causes of death worldwide, accurate primary tumor type prediction is critical in identifying genetic factors that can inhibit or slow tumor progression. There have been efforts to categorize primary tumor types with gene expression data using machine learning, and more recently with deep learning, in the last several years. Methods: In this paper, we developed four 1-dimensional (1D) Convolutional Neural Network (CNN) models to classify RNA-seq count data as one of 17 highly represented primary tumor types or 32 primary tumor types regardless of imbalanced representation. Additionally, we adapted the models to take as input either all Ensembl genes (60,483) or protein coding genes only (19,758). Unlike previous work, we avoided selection bias by not filtering genes based on expression values. RNA-seq count data expressed as FPKM-UQ of 9,025 and 10,940 samples from The Cancer Genome Atlas (TCGA) were downloaded from the Genomic Data Commons (GDC) corresponding to 17 and 32 primary tumor types respectively for training and validating the models. Results: All 4 1D-CNN models had an overall accuracy of 94.7% to 97.6% on the test dataset. Further evaluation indicates that the models with protein coding genes only as features performed with better accuracy compared to the models with all Ensembl genes for both 17 and 32 primary tumor types. For all models, the accuracy by primary tumor type was above 80% for most primary tumor types. Conclusions: We packaged all 4 models as a Python-based deep learning classification tool called TULIP (TUmor CLassIfication Predictor) for performing quality control on primary tumor samples and characterizing cancer samples of unknown tumor type. Further optimization of the models is needed to improve the accuracy of certain primary tumor types.

Indexed as

Convolutional neural networkdeep learningRNA-seqThe Cancer Genome Atlas (TCGA)tumor classification

Identifiers

PMID36507076
PMCPMC9729992
OpenAlexW4311007152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.